Skip to main content

Together we are beating cancer

Donate now

Personalised medicine

Showing 12 out of 89 results
2D image of scientist hands with a cancer vaccine vial and needle
  • Science & Technology
  • Health & Medicine

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 8 August 2024

8 August 2024

Two cancer researchers looking at a cell image on screen

Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs. Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs.

by Cancer Research UK | In depth | 21 November 2023

21 November 2023

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

by Alex Lathbridge | Analysis | 15 July 2020

15 July 2020

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods. Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

by Alex Lathbridge | Analysis | 18 June 2020

18 June 2020

Image of a breast cancer cell

A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests. A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests.

by Cancer Research UK | News | 7 August 2019

7 August 2019